Competitive studies relating to tryptophan binding to rat hepatic nuclear envelopes as a sensitive assay for unknown compounds
- 22 November 1992
- journal article
- Published by Elsevier in Toxicology
- Vol. 76 (1) , 89-100
- https://doi.org/10.1016/0300-483x(92)90021-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inhibitory effect of demoxepam on tryptophan binding to rat hepatic nucleiBiochemical Medicine and Metabolic Biology, 1992
- Identification of substances formed by decomposition of peak E substance in tryptophanFood and Chemical Toxicology, 1992
- The Cause and Pathogenesis of the Eosinophilia-Myalgia SyndromeAnnals of Internal Medicine, 1992
- Characterization of "Peak E," a Novel Amino Acid Associated with Eosinophilia-Myalgia SyndromeScience, 1990
- L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Journal of Clinical Investigation, 1990
- An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan UseNew England Journal of Medicine, 1990
- Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturerJAMA, 1990
- Identification and immunohistochemical localization of a tryptophan binding protein in nuclear envelopes of rat liverArchives of Biochemistry and Biophysics, 1988
- Evidence for involvement of nuclear envelope nucleoside triphosphatase in nucleocytoplasmic translocation of ribonucleoproteinNature, 1976
- Nuclei from Rat Liver: Isolation Method That Combines Purity with High YieldScience, 1966